24th EHA Annual Meeting Published June 14, 2019 IMG 5715 « ‹ 1 of 4 › » Recent news» Daratumumab becomes the first FDA-approved treatment for patients with newly diagnosed light chain (AL) amyloidosis» Watch the webinar on ASH 2020 myeloma and AL amyloidosis highlights
